Clinical applications of textural analysis in non-small cell lung cancer I Phillips, M Ajaz, V Ezhil, V Prakash, S Alobaidli, SJ McQuaid, C South, ... The British journal of radiology 91 (1081), 20170267, 2018 | 43 | 2018 |
Comprehensive geriatric assessment in 326 older women with early breast cancer DO Okonji, R Sinha, I Phillips, D Fatz, A Ring British journal of cancer 117 (7), 925-931, 2017 | 38 | 2017 |
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer M Stares, TE Ding, C Stratton, F Thomson, M Baxter, H Cagney, ... ESMO open 7 (2), 100445, 2022 | 35 | 2022 |
Stereotactic ablative body radiotherapy versus radical radiotherapy: comparing real-world outcomes in stage I lung cancer I Phillips, S Sandhu, M Lüchtenborg, S Harden Clinical Oncology 31 (10), 681-687, 2019 | 33 | 2019 |
Normal tissue complication probability (NTCP) modelling of severe acute mucositis using a novel oral mucosal surface organ at risk JA Dean, LC Welsh, KH Wong, A Aleksic, E Dunne, MR Islam, A Patel, ... Clinical oncology 29 (4), 263-273, 2017 | 32 | 2017 |
Aspirin as a treatment for cancer I Phillips, R Langley, D Gilbert, A Ring Clinical Oncology 25 (6), 333-335, 2013 | 27 | 2013 |
Hypoalbuminaemia as a prognostic biomarker of first-line treatment resistance in metastatic non-small cell lung cancer M Stares, A Swan, K Cumming, TE Ding, J Leach, C Stratton, F Thomson, ... Frontiers in Nutrition 8, 734735, 2021 | 26 | 2021 |
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series J McDonald, J Sayers, SD Anker, J Arends, TR Balstad, V Baracos, ... Journal of cachexia, sarcopenia and muscle 14 (5), 1932-1948, 2023 | 21 | 2023 |
Androgen deprivation therapy and the re-emergence of parenteral estrogen in prostate cancer I Phillips, SIA Shah, T Duong, P Abel, RE Langley Oncology & hematology review 10 (1), 42, 2014 | 21 | 2014 |
Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk JA Dean, LC Welsh, D McQuaid, KH Wong, A Aleksic, E Dunne, MR Islam, ... Radiotherapy and Oncology 119 (1), 166-171, 2016 | 18 | 2016 |
Nutritional status and symptom burden in advanced non-small cell lung cancer: results of the dietetic assessment and intervention in lung cancer (DAIL) trial I Phillips, L Allan, A Hug, N Westran, C Heinemann, M Hewish, A Mehta, ... BMJ supportive & palliative care 13 (e1), e213-e219, 2023 | 17 | 2023 |
Prehabilitation services for people diagnosed with cancer in Scotland–Current practice, barriers and challenges to implementation D Provan, G McLean, SJ Moug, I Phillips, AS Anderson The Surgeon 20 (5), 284-290, 2022 | 16 | 2022 |
The stability of imaging biomarkers in radiomics: a framework for evaluation HYC Wang, EM Donovan, A Nisbet, CP South, S Alobaidli, V Ezhil, ... Physics in Medicine & Biology 64 (16), 165012, 2019 | 9 | 2019 |
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series OM Vagnildhaug, TR Balstad, I Ottestad, A Bye, C Greil, J Arends, ... Journal of Cachexia, Sarcopenia and Muscle 15 (2), 513-535, 2024 | 7 | 2024 |
Real-world impact of SABR on stage I non-small-cell lung cancer outcomes at a scottish cancer centre M Stares, G Lewis, M Vallet, A Killean, G Tramonti, A Patrizio, M Mackean, ... Cancers 15 (5), 1431, 2023 | 7 | 2023 |
Immune-related adverse events, biomarkers of systemic inflammation, and survival outcomes in patients receiving pembrolizumab for non-small-cell lung cancer G Raynes, M Stares, S Low, D Haron, H Sarwar, D Abhi, C Barrie, B Laird, ... Cancers 15 (23), 5502, 2023 | 6 | 2023 |
Optimising outcomes in non small cell lung cancer: targeting cancer cachexia I Phillips, M Stares, L Allan, J Sayers, R Skipworth, B Laird Frontiers in Bioscience-Landmark 27 (4), 129, 2022 | 6 | 2022 |
Dietetic assessment and intervention in lung cancer I Phillips, A Hug, L Allan, V Ezhil Current Opinion in Supportive and Palliative Care 13 (4), 311-315, 2019 | 6 | 2019 |
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series MS Yule, J Thompson, K Leesahatsawat, MS Sousa, SD Anker, J Arends, ... Journal of Cachexia, Sarcopenia and Muscle, 2024 | 5 | 2024 |
Early prehabilitation in suspected locally advanced and metastatic lung cancer I Phillips, R Petrie, L Allan, P Hall, A Walton, D McMillan, C Peacock, ... BMJ Supportive & Palliative Care 13 (e3), e908-e911, 2023 | 5 | 2023 |